A detailed history of Gries Financial LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gries Financial LLC holds 2,664 shares of NVO stock, worth $232,753. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,664
Previous 2,768 3.76%
Holding current value
$232,753
Previous $395,000 19.75%
% of portfolio
0.07%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$119.07 - $145.42 $12,383 - $15,123
-104 Reduced 3.76%
2,664 $317,000
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $227,909 - $303,373
-2,232 Reduced 44.64%
2,768 $355,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $227,350 - $498,850
2,500 Added 100.0%
5,000 $454,000
Q2 2021

Aug 09, 2021

BUY
$67.66 - $84.76 $169,150 - $211,900
2,500 New
2,500 $246,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.